Literature DB >> 33287316

Impact of Pulse Wave Velocity and Parameters Reflecting Android Type Fat Distribution on Left Ventricular Diastolic Dysfunction in Patients with Chronic Coronary Syndromes.

Marlena Paniczko1, Małgorzata Chlabicz1,2, Jacek Jamiołkowski1, Paweł Sowa1, Małgorzata Szpakowicz1, Magda Łapińska1, Marcin Kondraciuk1, Katarzyna Ptaszyńska-Kopczyńska3, Andrzej Raczkowski1, Anna Szpakowicz3, Karol Adam Kamiński1,3.   

Abstract

BACKGROUND: Left ventricular diastolic dysfunction (LVDD) is caused by a decreased left ventricle relaxation and is associated with an increased risk of symptomatic heart failure (HF) and excessive mortality. AIM: To evaluate the frequency and factors related to LVDD in the population with chronic coronary syndromes (CCS).
METHODS: 200 patients (mean age 63.18 ± 8.12 years, 75.5% male) with CCS were included. LVDD was diagnosed based on the recent echocardiography guidelines.
RESULTS: LVDD was diagnosed in 38.5% of CCS population. From the studied factors, after adjustment for age, sex, and N-terminal pro-brain natriuretic peptide (NT-proBNP), LVDD associated positively with android/gynoid (A/G) fat mass ratio, left ventricular mass index (LVMI), and negatively with Z-score and left ventricular ejection fraction (LVEF). In stepwise backward logistic regression analysis, the strongest factors associated with LVDD were pulse wave velocity value, handgrip strength and waist to hip ratio (WHR).
CONCLUSIONS: LVDD is common among CCS patients and it is associated with parameters reflecting android type fat distribution regardless of NT-proBNP and high-sensitivity troponin T concentrations. Deterioration in diastolic dysfunction is linked with increased aortic stiffness independently of age and sex. Further studies evaluating the effects of increasing physical fitness and lowering abdominal fat accumulations on LVDD in CCS patients should be considered.

Entities:  

Keywords:  android fat distribution; chronic coronary syndromes; left ventricular diastolic dysfunction

Year:  2020        PMID: 33287316     DOI: 10.3390/jcm9123924

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  3 in total

1.  IGFBP7 Concentration May Reflect Subclinical Myocardial Damage and Kidney Function in Patients with Stable Ischemic Heart Disease.

Authors:  Anna Lisowska; Anna Szyszkowska; Małgorzata Knapp; Magda Łapińska; Marcin Kondraciuk; Inga Kamińska; Tomasz Hryszko; Katarzyna Ptaszyńska-Kopczyńska; Karol Kamiński
Journal:  Biomolecules       Date:  2022-02-08

2.  Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.

Authors:  Steven H J Hageman; Ailsa J McKay; Peter Ueda; Laura H Gunn; Tomas Jernberg; Emil Hagström; Deepak L Bhatt; Ph Gabriel Steg; Kristi Läll; Reedik Mägi; Mari Nordbø Gynnild; Hanne Ellekjær; Ingvild Saltvedt; José Tuñón; Ignacio Mahíllo; Álvaro Aceña; Karol Kaminski; Malgorzata Chlabicz; Emilia Sawicka; Taavi Tillman; John W McEvoy; Emanuele Di Angelantonio; Ian Graham; Dirk De Bacquer; Kausik K Ray; Jannick A N Dorresteijn; Frank L J Visseren
Journal:  Eur Heart J       Date:  2022-05-07       Impact factor: 35.855

3.  How Unawareness of Weight Excess Can Increase Cardiovascular Risk?

Authors:  Magdalena Zalewska; Jacek Jamiołkowski; Małgorzata Chlabicz; Magda Łapińska; Marlena Dubatówka; Marcin Kondraciuk; Adam Hermanowicz; Karol Adam Kamiński
Journal:  J Clin Med       Date:  2022-08-23       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.